Targeting the antisense nucleotide (ASO) of LINC02568 significantly inhibited the growth as well as tumor formation of estrogen receptor-positive breast cancer cells and restored the sensitivity of tamoxifen-resistant breast cancer cells to tamoxifen. This evidence concerns the gene ESR1 and breast carcinoma.